European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Oncology drug tenders in Czechia — market report, April 2026

Oncology drug tenders in Czechia in April 2026: 91 tenders published (-12% month on month, +3% year on year), estimated at €73,955,747 in total, and 191 contracts awarded (+72% month on month, +7% year on year), worth €122,059,124 (awarded value). Buyers with the most tenders: Fakultní nemocnice Olomouc (8), Fakultní nemocnice Ostrava (6) and Krajská zdravotní, a.s. (6); most contracts won: Takeda Pharmaceuticals Czech Republic s.r.o. (17), ROCHE s.r.o. (16) and Janssen-Cilag s.r.o. (8). On average 2.0 bids per contract; 76% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
91
Contracts awarded
191
Contract value awarded
€122,059,124
Bids per contract
2.0
Tenders published per month
050100150Apr 25: 88Apr 25: 88Apr 25May 25: 82May 25: 82May 25Jun 25: 86Jun 25: 86Jun 25Jul 25: 92Jul 25: 92Jul 25Aug 25: 96Aug 25: 96Aug 25Sep 25: 76Sep 25: 76Sep 25Oct 25: 118Oct 25: 118Oct 25Nov 25: 72Nov 25: 72Nov 25Dec 25: 84Dec 25: 84Dec 25Jan 26: 82Jan 26: 82Jan 26Feb 26: 103Feb 26: 103Feb 26Mar 26: 104Mar 26: 104Mar 26Apr 26: 91Apr 26: 9191Apr 26
Contracts awarded per month
050100150200Apr 25: 179Apr 25: 179Apr 25May 25: 174May 25: 174May 25Jun 25: 146Jun 25: 146Jun 25Jul 25: 125Jul 25: 125Jul 25Aug 25: 115Aug 25: 115Aug 25Sep 25: 128Sep 25: 128Sep 25Oct 25: 166Oct 25: 166Oct 25Nov 25: 143Nov 25: 143Nov 25Dec 25: 107Dec 25: 107Dec 25Jan 26: 89Jan 26: 89Jan 26Feb 26: 104Feb 26: 104Feb 26Mar 26: 111Mar 26: 111Mar 26Apr 26: 191Apr 26: 191191Apr 26

The highlighted bar is April 2026. Hover a bar for its figure; the table below has every value.

FigureApril 2026March 2026ChangeApril 2025Change
Tenders published91104-12%88+3%
Estimated value€73,955,747€62,244,898+19%€74,497,165-1%
Buyers109+11%6+67%
Contracts awarded191111+72%179+7%
Contract value (awarded)€122,059,124€54,436,771+124%€109,124,906+12%
Winners1312+8%10+30%
Bids per contract2.04.0—2.3—
Single-bid contracts76%66%—69%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Královéhradecký kraj 15
  • Hlavní město Praha 13
  • Olomoucký kraj 8
  • Ústecký kraj 6
  • Moravskoslezský kraj 5

Procedures

  • not stated 40
  • Open procedure 31
  • Other procedure 20

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Oncology and immunomodulating drugs

Questions and answers

How many oncology drug tenders were published in Czechia in April 2026?
91 (by 10 buyers); for comparison, March 2026: 104, April 2025: 88.
Who won the most oncology drug tenders in Czechia in April 2026?
By number of contracts: Takeda Pharmaceuticals Czech Republic s.r.o. (17), ROCHE s.r.o. (16), Janssen-Cilag s.r.o. (8), Merck Sharp & Dohme s.r.o. (8) and ELI LILLY ČR, s.r.o. (5); 13 companies won contracts in all.
Which buyers published the most oncology drug tenders in April 2026?
Fakultní nemocnice Olomouc (8), Fakultní nemocnice Ostrava (6), Krajská zdravotní, a.s. (6), Fakultní Thomayerova nemocnice (3) and Revmatologický ústav (1).
How competitive were oncology drug tenders in Czechia in April 2026?
On average 2.0 bids per contract (151 contracts with a known number of bids); 76% of contracts had a single bid.
What were the contracts worth in April 2026?
€122,059,124 (awarded value, 191 contracts); median about €690,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.